1,390 reports of this reaction
1.2% of all ACETAMINOPHEN AND CODEINE reports
#16 most reported adverse reaction
BLISTER is the #16 most commonly reported adverse reaction for ACETAMINOPHEN AND CODEINE, manufactured by Amneal Pharmaceuticals LLC. There are 1,390 FDA adverse event reports linking ACETAMINOPHEN AND CODEINE to BLISTER. This represents approximately 1.2% of all 113,152 adverse event reports for this drug.
Patients taking ACETAMINOPHEN AND CODEINE who experience blister should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLISTER is a less commonly reported adverse event for ACETAMINOPHEN AND CODEINE, but still significant enough to appear in the safety profile.
In addition to blister, the following adverse reactions have been reported for ACETAMINOPHEN AND CODEINE:
The following drugs have also been linked to blister in FDA adverse event reports:
BLISTER has been reported as an adverse event in 1,390 FDA reports for ACETAMINOPHEN AND CODEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLISTER accounts for approximately 1.2% of all adverse event reports for ACETAMINOPHEN AND CODEINE, making it a notable side effect.
If you experience blister while taking ACETAMINOPHEN AND CODEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.